An extended-release version of deucrictibant reduced patients’ mean monthly attack rate by 83% compared to placebo, meeting ...
Anthropic posts a corporate development role for life sciences dealmaking, paying up to $600,000, as its biotech push and IPO ...
Tech giants & startups like Google, OpenAI, Amazon, Anthropic, Whoop, Oura now offer AI assistants using medical records.
An experimental CAR-T called arlo-cel improved response rates in patients with relapsed and refractory multiple myeloma who ...
Amgen's Imdelltra plus AstraZeneca's Imfinzi improves overall survival in extensive-stage small cell lung cancer in Phase 3.
BrainChild Bio will use Tuesday’s $116 million Series A to complete a single pivotal trial that has already ...
Beam's BEAM-302 base editing therapy sustains AAT levels through one year in AATD as the pivotal Phase 1/2 cohort advances.
Sanofi, AstraZeneca, Upstream Bio and GSK detail fresh respiratory trial data at ERS for lunsekimig, tozorakimab, verekitug and Nucala.
Apps like Doctronic, Sharecare & ChatGPT now let patients access medical records via AI, aided by TEFCA & CMS, though Epic's ...
Roivant's Pulmovant reports positive mosliciguat Phase 2 data in PH-ILD, topping Wall Street's bar for Phase 3 advancement.
Three months ago, Charles River Laboratories announced it would shed its manufacturing unit, which has a focus on cell and gene therapies. And, according to its CEO Birgit Girshick, ...
European growth debt fund Claret Capital Partners raises €575M, with a third earmarked for biotech, medtech and diagnostics ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results